Furthermore, 4 (14%), 0 (0%), and 5 (11%) of WR‐, SN‐, and LN‐DLBCL, respectively, had double expression of MYC and BCL2 (p = 0.801). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.